Linked Life Data

15984515

Source:http://linkedlifedata.com/resource/pubmed/id/15984515

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2005-6-29
pubmed:abstractText
The treatment of choice for limited small-cell lung cancer (SCLC) is platinum-based chemotherapy combined with early, concurrent thoracic radiotherapy with a hyperfractionated regimen. The standard chemotherapy for extensive SCLC in Japan is the combination of irinotecan and cisplatin. There are expectations for new and effective molecular-target-based drugs for SCLC.
pubmed:language
jpn
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0385-0684
pubmed:author
pubmed:issnType
Print
pubmed:volume
32
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
777-82
pubmed:dateRevised
2006-11-20
pubmed:meshHeading
pubmed:year
2005
pubmed:articleTitle
[Treatment of small cell lung cancer].
pubmed:affiliation
Dept. of Thoracic Oncology, Hyogo Medical Center for Adults, Akashi City, Japan.
pubmed:publicationType
Journal Article, English Abstract, Review